Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia

Abstract excerpt

High-throughput omics have proven invaluable in studying human disease, and yet day-to-day clinical practice still relies on physiological, non-omic markers. The metabolic syndrome, for example, is diagnosed and monitored by blood and urine indices such as blood cholesterol levels. Nevertheless, the association between the molecular and the physiological manifestations of the disease, especially in response to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adipose Tissue and Metabolism
• Share to Bioinformatics and Genomic Networks
• Share to Single-cell and spatial transcriptomics